1. Home
  2. LPSN vs ATNM Comparison

LPSN vs ATNM Comparison

Compare LPSN & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

N/A

Current Price

$2.83

Market Cap

35.1M

Sector

Technology

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.10

Market Cap

31.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPSN
ATNM
Founded
1995
2000
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.1M
31.7M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
LPSN
ATNM
Price
$2.83
$1.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
227.5K
166.9K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
0.71
Revenue
$249,838,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.58
Revenue Growth
N/A
11.11
52 Week Low
$0.39
$0.74
52 Week High
$7.54
$1.81

Technical Indicators

Market Signals
Indicator
LPSN
ATNM
Relative Strength Index (RSI) 69.17 70.97
Support Level $2.44 $0.94
Resistance Level $2.88 $1.27
Average True Range (ATR) 0.24 0.07
MACD 0.04 0.04
Stochastic Oscillator 85.60 91.56

Price Performance

Historical Comparison
LPSN
ATNM

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Companies enterprise-class digital customer conversation platform, is trusted by the brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United States, Asia-Pacific, Latin America, and Europe.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: